Australia markets close in 2 hours 11 minutes
  • ALL ORDS

    7,702.00
    -57.80 (-0.74%)
     
  • ASX 200

    7,404.10
    -56.10 (-0.75%)
     
  • AUD/USD

    0.7297
    +0.0001 (+0.02%)
     
  • OIL

    72.42
    -0.19 (-0.26%)
     
  • GOLD

    1,758.70
    +2.00 (+0.11%)
     
  • BTC-AUD

    65,680.93
    -34.48 (-0.05%)
     
  • CMC Crypto 200

    1,226.16
    -7.13 (-0.58%)
     
  • AUD/EUR

    0.6197
    +0.0004 (+0.07%)
     
  • AUD/NZD

    1.0318
    +0.0014 (+0.13%)
     
  • NZX 50

    13,142.38
    +62.87 (+0.48%)
     
  • NASDAQ

    15,515.91
    +12.38 (+0.08%)
     
  • FTSE

    7,027.48
    +10.99 (+0.16%)
     
  • Dow Jones

    34,751.32
    -63.07 (-0.18%)
     
  • DAX

    15,651.75
    +35.75 (+0.23%)
     
  • Hang Seng

    24,770.34
    +102.49 (+0.42%)
     
  • NIKKEI 225

    30,490.76
    +167.42 (+0.55%)
     

Universe Pharmaceuticals INC to Announce Unaudited Financial Results for The First Six Months of Fiscal Year 2021 on August 2, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Ji’an, Jiangxi, China, July 30, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that it will release its unaudited financial results for the first six months of fiscal year 2021 ended March 31, 2021 on Monday, August 2, 2021 before the market opens. The Company intends to file its financial results on Form 6-K with the Securities and Exchange Commission and release its earnings press release accordingly.

About Universe Pharmaceuticals INC

Universe Pharmaceuticals INC, headquartered in Ji’an, Jiangxi, China, is a pharmaceutical producer and distributor in China. The Company specializes in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. The Company also distributes and sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Currently, the Company’s products are sold in 30 provinces of China. For more information, visit the company’s website at http://www.universe-pharmacy.com/.

Forward-Looking Statements

All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the SEC.

For more information, please contact:

Ascent Investors Relations LLC
Tina Xiao
President
Phone: 917-609-0333
Email: tina.xiao@ascent-ir.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting